KI
AUPH icon

Kula Investments’s Aurinia Pharmaceuticals AUPH Stock Holding History

Kula Investments’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$397K Buy
+36,199
New +$319K 0.1% 367

Other funds holding AUPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Kula Investments's AUPH Position: Q1 2023 in Review

Kula Investments opened a new position in Aurinia Pharmaceuticals (AUPH) in Q1 2023: 36,199 shares worth $397K. The stake represents 0.1% of the portfolio and ranks #367 among its holdings.

186 funds tracked by Wall St. Rank hold AUPH as of Q1 2023.

  • Kula Investments held 36,199 shares of Aurinia Pharmaceuticals worth $397K as of Q1 2023.
  • Aurinia Pharmaceuticals was a new Kula Investments position in Q1 2023.
  • Aurinia Pharmaceuticals made up 0.1% of Kula Investments's portfolio in Q1 2023, its #367 holding.
  • 186 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2023.

Based on Kula Investments's 13F filing for Q1 2023, filed 15 May 2023.